These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3547947)

  • 1. Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
    Hess AD; Vogelsang GB; Heyd J; Beschorner WE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2683-6. PubMed ID: 3547947
    [No Abstract]   [Full Text] [Related]  

  • 2. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
    Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
    J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats.
    Bos GM; Majoor GD; van Breda Vriesman PJ
    Clin Exp Immunol; 1988 Dec; 74(3):443-8. PubMed ID: 2976623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin-induced autoimmunity: a role for marrow-derived cells presenting self antigens in the thymus.
    Babcock SK; Georgiu H; Kotzin B; Bellgau D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):220-1. PubMed ID: 2650108
    [No Abstract]   [Full Text] [Related]  

  • 5. Perturbation of T-cell differentiation in lethally irradiated rats reconstituted with syngeneic bone marrow and treated with cyclosporin-A.
    Bos GM; Majoor GD; Van Breda Vriesman PJ
    Thymus; 1989; 14(1-3):155-61. PubMed ID: 2516375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T4+ cells can initiate human graft-versus-host disease.
    Atkinson K; Cooley M; Farrelly H; O'Flaherty E; Concannon A; Dodds A; Biggs J
    Transplant Proc; 1987 Apr; 19(2):2879-81. PubMed ID: 3105126
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
    Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
    J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
    Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG
    Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961
    [No Abstract]   [Full Text] [Related]  

  • 9. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
    Hess AD; Thoburn CJ; Chen W; Bright AE
    Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of syngeneic graft-versus-host disease by autosuppressor mechanisms.
    Hess AD; Fischer AC; Beschorner WE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3013-5. PubMed ID: 2523169
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
    Thoburn CJ; Miura Y; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA; James T; Hardy MA; Oluwole SF
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
    Chen W; Thoburn C; Hess AD
    J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-helper lymphocytes and syngeneic graft-versus-host disease.
    Bos GM; Majoor GD; van de Gaar MJ; van Breda Vriesman PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3016-7. PubMed ID: 2523170
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
    Fischer AC; Ruvolo PP; Burt R; Horwitz LR; Bright EC; Hess JM; Beschorner WE; Hess AD
    J Immunol; 1995 Apr; 154(8):3713-25. PubMed ID: 7706714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
    Severino ME; Laulis MK; Horwitz LR; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):520-3. PubMed ID: 8438399
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
    Hess AD; Horwitz LR; Laulis MK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
    [No Abstract]   [Full Text] [Related]  

  • 19. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
    Hess AD; Jones RC; Santos GW
    Bone Marrow Transplant; 1993; 12 Suppl 3():S65-9. PubMed ID: 8124261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes.
    Fischer AC; Hess AD
    J Exp Med; 1990 Jul; 172(1):85-94. PubMed ID: 2358786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.